Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ICAD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ICAD

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

icad inc

ICAD
Current price
3.87 USD 0 USD (0.00%)
Last closed 3.73 USD
ISIN US44934S2068
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 105 496 200 USD
Yield for 12 month +197.69 %
1Y
3Y
5Y
10Y
15Y
ICAD
21.11.2021 - 28.11.2021

iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Detection solutions include advanced artificial intelligence and image analysis workflow solutions to identifying pathologies and pinpointing prevalent cancers earlier; and a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging, and computed tomography. In addition, the company suite offers solutions for cancer detection, density assessment, and personalized risk evaluation based on a 2D or 3D mammogram's collection of images. Additionally, its density assessment standardizes and simplifies breast density reporting by algorithmically examining a woman's breast anatomy from the mammogram image. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Address: 2 Townsend West, Nashua, NH, United States, 03063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.75 USD

P/E Ratio

Dividend Yield

Financials ICAD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ICAD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+19 608 000 USD

Last Year

+17 318 000 USD

Current Quarter

+4 874 000 USD

Last Quarter

+5 408 000 USD

Current Year

+16 635 000 USD

Last Year

+14 536 000 USD

Current Quarter

+4 189 000 USD

Last Quarter

+4 670 000 USD
EBITDA -5 081 000 USD
Operating Margin TTM -23.16 %
Price to Earnings
Return On Assets TTM -9.03 %
PEG Ratio -0.56
Return On Equity TTM -16.53 %
Wall Street Target Price 3.75 USD
Revenue TTM 19 528 000 USD
Book Value 1.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.60 %
Dividend Yield
Gross Profit TTM 17 166 000 USD
Earnings per share -0.19 USD
Diluted Eps TTM -0.19 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -26.77 %

Stock Valuation ICAD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.39
Price Sales TTM 5.40
Enterprise Value EBITDA -3.36
Price Book MRQ 3.43

Technical Indicators ICAD

For 52 Weeks

1.19 USD 4.02 USD
50 Day MA 3.77 USD
Shares Short Prior Month 269 602
200 Day MA 2.57 USD
Short Ratio 0.70
Shares Short 232 422
Short Percent 1.05 %